Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionAuxier Asset Management
Latest Disclosed Ownership8,616 shares
Latest Disclosed Value $ 1,200,812
Auxier Asset Management reports 2.01% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - Auxier Asset Management filed a 13F-HR form disclosing ownership of 8,616 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,200,812 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 8,793 shares of Gilead Sciences, Inc.. This represents a change in shares of -2.01% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F Gilead Sciences COM 375558103 8,616 -177 -2.01 1,201 11.21 0.1724
2026-02-17 2025-12-31 13F Gilead Sciences COM 375558103 8,793 -200 -2.22 1,079 8.12 0.1518
2025-11-19 2025-09-30 13F Gilead Sciences COM 375558103 8,993 -160 -1.75 998 -1.58 0.1399
2025-08-15 2025-06-30 13F Gilead Sciences COM 375558103 9,153 -45 -0.49 1,015 -1.55 0.1491
2025-05-14 2025-03-31 13F Gilead Sciences COM 375558103 9,198 -507 -5.22 1,031 14.96 0.1536
2025-02-19 2024-12-31 13F Gilead Sciences COM 375558103 9,705 -2,072 -17.59 896 -9.22 0.1390
2024-11-14 2024-09-30 13F Gilead Sciences COM 375558103 11,777 -48 -0.41 987 21.70 0.1459
2024-08-13 2024-06-30 13F Gilead Sciences COM 375558103 11,825 -10 -0.08 811 -6.35 0.1285
2024-05-08 2024-03-31 13F Gilead Sciences COM 375558103 11,835 -382 -3.13 867 -12.44 0.1319
2024-02-22 2023-12-31 13F Gilead Sciences COM 375558103 12,217 -366 -2.91 990 4.99 0.1601
2023-11-21 2023-09-30 13F Gilead Sciences COM 375558103 12,583 -220 -1.72 943 -4.46 0.1609
2023-08-17 2023-06-30 13F Gilead Sciences COM 375558103 12,803 -35 -0.27 987 -7.42 0.1637
2023-05-15 2023-03-31 13F Gilead Sciences COM 375558103 12,838 -370 -2.80 1,065 -6.00 0.1838
2023-02-17 2022-12-31 13F Gilead Sciences COM 375558103 13,208 -30 -0.23 1,134 38.68 0.1957
2022-11-15 2022-09-30 13F Gilead Sciences COM 375558103 13,238 -70 -0.53 817 -0.73 0.1574
2022-08-11 2022-06-30 13F Gilead Sciences COM 375558103 13,308 0 0.00 823 4.05 0.1470
2022-05-17 2022-03-31 13F Gilead Sciences COM 375558103 13,308 -150 -1.11 791 -19.04 0.1254
2022-03-01 2021-12-31 13F Gilead Sciences COM 375558103 13,458 -490 -3.51 977 0.31 0.1517
2021-11-18 2021-09-30 13F Gilead Sciences COM 375558103 13,948 0 0.00 974 1.46 0.1648
2021-08-18 2021-06-30 13F Gilead Sciences COM 375558103 13,948 -150 -1.06 960 5.38 0.1591
2021-05-17 2021-03-31 13F Gilead Sciences COM 375558103 14,098 0 0.00 911 10.96 0.1567
2021-03-05 2020-12-31 13F Gilead Sciences COM 375558103 14,098 -1,355 -8.77 821 -15.88 0.1524
2021-03-05 2020-09-30 13F Gilead Sciences COM 375558103 15,453 3,703 31.51 976 7.96 0.2041
2020-08-20 2020-06-30 13F Gilead Sciences COM 375558103 11,750 -50 -0.42 904 2.49 0.1994
2020-05-15 2020-03-31 13F Gilead Sciences COM 375558103 11,800 1,850 18.59 882 36.32 0.2202
2020-02-21 2019-12-31 13F Gilead Sciences COM 375558103 9,950 -100 -1.00 647 1.57 0.1204
2019-11-15 2019-09-30 13F Gilead Sciences COM 375558103 10,050 0 0.00 637 -6.19 0.1281
2019-08-15 2019-06-30 13F Gilead Sciences COM 375558103 10,050 -1,780 -15.05 679 -11.70 0.1354
2019-05-14 2019-03-31 13F Gilead Sciences COM 375558103 11,830 1,625 15.92 769 20.53 0.1580
2019-02-13 2018-12-31 13F Gilead Sciences COM 375558103 10,205 -1,345 -11.65 638 -28.48 0.1421
2018-11-19 2018-09-30 13F Gilead Sciences COM 375558103 11,550 3,075 36.28 892 48.67 0.1682
2018-08-15 2018-06-30 13F Gilead Sciences COM 375558103 8,475 100 1.19 600 -4.91 0.1201
2018-05-14 2018-03-31 13F Gilead Sciences COM 375558103 8,375 95 1.15 631 6.41 0.1264
2018-02-14 2017-12-31 13F Gilead Sciences COM 375558103 8,280 150 1.85 593 -10.02 0.1138
2017-11-09 2017-09-30 13F Gilead Sciences COM 375558103 8,130 1,357 20.04 659 37.58 0.1338
2017-08-16 2017-06-30 13F Gilead Sciences COM 375558103 6,773 96 1.44 479 5.51 0.0979
2017-05-12 2017-03-31 13F Gilead Sciences COM 375558103 6,677 1,200 21.91 454 15.82 0.0951
2017-02-28 2016-12-31 13F Gilead Sciences COM 375558103 5,477 695 14.53 392 3.70 0.0852
2016-11-21 2016-09-30 13F Gilead Sciences COM 375558103 4,782 1,800 60.36 378 51.81 0.0846
2016-08-04 2016-06-30 13F Gilead Sciences COM 375558103 2,982 0 0.00 249 -9.12 0.0570
2016-05-13 2016-03-31 13F Gilead Sciences COM 375558103 2,982 700 30.67 274 18.61 0.0649
2016-02-08 2015-12-31 13F Gilead Sciences COM 375558103 2,282 2,282 0.00 231 0.0524
2015-11-10 2015-03-31 13F/A-1 Gilead Sciences COM 375558103 0 0 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.